# Fluticasone/Salmeterol (FP/SM) Versus Double the Dose Fluticasone (FP) in Patients With Mild to Moderate Asthma

> **NCT00830505** · PHASE4 · COMPLETED · sponsor: **University of Dundee** · enrollment: 38 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** fluticasone/salmeterol
- **DRUG:** fluticasone

## Key facts

- **NCT ID:** NCT00830505
- **Lead sponsor:** University of Dundee
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2019-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00830505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00830505, "Fluticasone/Salmeterol (FP/SM) Versus Double the Dose Fluticasone (FP) in Patients With Mild to Moderate Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00830505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*